Elie Hanania, Ph.D

VP, Process Development Viral Vector Technologies

Elie Hanania, obtained his Ph.D. in Cell and Molecular Biology from the University of Texas Medical Branch (Galveston, Texas). He did his postdoctoral training at the M.D. Anderson Cancer Center (Houston, TX) focusing on hematology and oncology gene therapy applications.  Elie developed state-of-the art assays for minimal residual diseases related to stem cell gene therapy as the Process Development Manager at At SyStemix – A Novartis Company in Palo Alto, CA. As the Associate Director at Cyntellect in San Diego, CA, Elie managed the research and clinical applications for the Company’s laser platform device.

Focusing on Cell and Gene Therapy CDMO Services, Elie joined Progenitor Cell Therapy – a Hitachi Company in Mountain View, California and led their Process Development team. As the Head of Process Development at Millipore Sigma (Carlsbad, CA), Elie’s Team developed processes for a wide range of viral vector production/purification. Continuing his journey and focusing on large scale production of viral vectors, Elie lead the Upstream Process Development team at Fujifilm Diosynth Biotechnologies (College Station, TX).  Elie’s expertise spans academic, clinical and industry settings, with diverse experience in molecular and cell biology, virology, cell line development, primary and stem cells, device validation, process development, technology transfer, process characterization, animal models and assay development with implementation of empowering technologies for the advancement of Cell and Gene Therapy.

Close this popup.
We use cookies to improve your experience on our site. To find out more, read our Privacy Policy.